Accession Number: | 0001479290-21-000099 |
Date: | 2021-04-15 |
Issuer: | REVANCE THERAPEUTICS, INC. (RVNC) |
Original Submission Date: |
SJUTS DUSTIN S
C/O REVANCE THERAPEUTICS, INC
1222 DEMONBREUN STREET, SUITE 1001
NASHVILLE, TN 37203
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-04-15 | F | 411 | d | $28.16 | 65,098 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents the number of shares withheld by and surrendered to the issuer on april 15, 2021, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock award ("rsa") for 5,000 shares. the rsa vests in four equal annual installments from april 15, 2018, subject to mr. sjuts' continuous service (as defined in the issuer's 2014 equity incentive plan) on each vesting date. |